In the past too, Cipla has faced several top-level managerial exits, including two CEOs, two COOs and four CFOs over a span of six years, with the company being increasingly referred as “revolving doors” in the industry.
Original source: https://health.economictimes.indiatimes.com/news/pharma/top-deck-churn-at-cipla-over-unclear-strategy/72409765?utm_source=RSS&utm_medium=ETRSS